107 related articles for article (PubMed ID: 4408523)
21. Effect of long-term administration of paromomycin sulfate on the level of serum albumin and gamma-globulin in human cirrhosis.
Tarao K; Iwamura K
Tokai J Exp Clin Med; 1983 Nov; 8(4):349-57. PubMed ID: 6208639
[TBL] [Abstract][Full Text] [Related]
22. [Demonstration of antibodies against albumins in chronic hepatopathies; their relation to albumin turbidity and some other tests (author's transl)].
Fassati P; Jezková Z; Spízek J
Cas Lek Cesk; 1977 May; 116(19):584-7. PubMed ID: 880595
[No Abstract] [Full Text] [Related]
23. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease.
Klammt S; Mitzner S; Stange J; Brinkmann B; Drewelow B; Emmrich J; Liebe S; Schmidt R
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):257-63. PubMed ID: 17301654
[TBL] [Abstract][Full Text] [Related]
24. [Comparative serologic, histologic and biochemical studies in liver cirrhosis].
Denk H; Schnack H; Wiedermann G
Wien Klin Wochenschr; 1969 Mar; 81(10):192-5. PubMed ID: 5783404
[No Abstract] [Full Text] [Related]
25. Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man.
Tarao K; Iwamura K
Tokai J Exp Clin Med; 1983 Jan; 8(1):71-8. PubMed ID: 6612754
[TBL] [Abstract][Full Text] [Related]
26. [Cirrhosis and blood cholesterol. Apropos of 240 plasma determinations of total cholesterol in patients with cirrhosis of the liver].
Pequegnot H; Guerre J; de La Bouillerie B; Chretien JM; Gerard MJ; Babok A; Guerre Y; Fluteau G
Med Chir Dig; 1978; 7(2):137-40. PubMed ID: 661408
[No Abstract] [Full Text] [Related]
27. The prognostic value of clinical and laboratory data in patients with cirrhosis.
Winkel P; Juhl E; Tygstrup N
Scand J Gastroenterol Suppl; 1970; 7():181-7. PubMed ID: 5271842
[No Abstract] [Full Text] [Related]
28. Serum immunoglobulins and five serum proteins in extrahepatic obstructive jaundice and alcoholic cirrhosis. Immunoglobulins and proteins in liver diseases.
LoGrippo GA; Anselm K; Hayashi H
Am J Gastroenterol; 1971 Oct; 56(4):357-63. PubMed ID: 5117508
[No Abstract] [Full Text] [Related]
29. [The determination of pre- and postoperative serum cholinesterase activity with the Acholest method].
Weidemann H
Anaesthesist; 1965 Dec; 14(12):352-5. PubMed ID: 5870011
[No Abstract] [Full Text] [Related]
30. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
Van Thiel DH; George M; Fareed J
Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
[TBL] [Abstract][Full Text] [Related]
31. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
32. Nutritional indices in cirrhotic patients.
Piquet MA; Ollivier I; Gloro R; Castel H; Tiengou LE; Dao T
Nutrition; 2006 Feb; 22(2):216-7; author reply 218-9. PubMed ID: 16459237
[No Abstract] [Full Text] [Related]
33. Thymol turbidity and thymol flocculation tests in Nigerian control subjects.
Rocha-Afodu JT; Ogunlewe JO
Niger Med J; 1979 Jan; 9(1):112-6. PubMed ID: 380220
[No Abstract] [Full Text] [Related]
34. [Evaluation of hepaplastintest for liver disease. Effect of vitamin K administration on values of hepaplastintest (author's transl)].
Noda K
Rinsho Byori; 1976 Mar; 24(3):229-33. PubMed ID: 985931
[No Abstract] [Full Text] [Related]
35. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
36. [Determination of blood serum cholesterol esters with the use of tomatine in chronic liver diseases].
Tukalo EA; Okorokov AN; Vysotskaia TN
Lab Delo; 1980; (5):295-7. PubMed ID: 6156285
[No Abstract] [Full Text] [Related]
37. [Modification of serum albumin in pathology].
Bagdasar'ian SN; Troitskiĭ GV; Alakhov IuB
Dokl Akad Nauk SSSR; 1980; 255(1):222-4. PubMed ID: 7460747
[No Abstract] [Full Text] [Related]
38. [Application of the two-dimensional immunoelectrophoresis technic to the problem of cirrhosis].
Rebeyrotte P; Baujat JP; Labbé JP; Koutsoukos A
Pathol Biol (Paris); 1970; 18(11):653-61. PubMed ID: 4914155
[No Abstract] [Full Text] [Related]
39. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
Burkert K; Beckmann H
Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
[TBL] [Abstract][Full Text] [Related]
40. Natural history of hepatectomy regarding liver function: a study of both normal livers and livers with chronic hepatitis and cirrhosis.
Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
Hepatogastroenterology; 1998; 45(23):1795-801. PubMed ID: 9840150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
